Axsome Therapeutics, Inc. (AXSM)
227.72
-4.55
(-1.96%)
USD |
NASDAQ |
May 15, 16:00
227.75
+0.03
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Market Cap : 11.72B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 275.09B |
| Indivior Pharmaceuticals, Inc. | 4.345B |
| Eli Lilly & Co. | 896.13B |
| Esperion Therapeutics, Inc. | 803.19M |
| Ocular Therapeutix, Inc. | 2.006B |
Market Cap Related Metrics
| PS Ratio | 16.18 |
| Price to Book Value | 214.67 |
| Price | 227.72 |
| Earnings Yield | -1.64% |